Cancer Care Ontario | Action Cancer Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

369 Results

Document

Effective.png

Sep 2019

Document

Efficient.png

Sep 2019

Document

Equitable.png

Sep 2019

Document

BigBackground1.jpg

Sep 2019

Document

BigBackground2.jpg

Sep 2019

Document

BigBackground3.jpg

Sep 2019

Drug

Erwinia asparaginase

Other Name(s): Erwinase®

Quick Link(s):

Jan 2020

Document

Best Practice Guidance for Patient-Specific Quality Assurance (PSQA) for IMRT and VMAT Plan Delivery Verification

Nov 2019

Document

eCCOOntarioHealthVirtualTownHall3.jpg

Nov 2019

Document

BiosimilarPatients.pdf

Nov 2019

Document

BiosimilarPatients-FR.pdf

Nov 2019

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines: January to June 2019

Status: Current
ID: pet 2019-1
Version: N/A

Nov 2019

Pages